April 5, 2018 / 9:47 PM / 17 days ago

BRIEF-Aralez Pharmaceuticals Says Unit Entered Into Modification Of Contract

April 5 (Reuters) - Aralez Pharmaceuticals Inc:

* ARALEZ PHARMA - UNIT ENTERED INTO MODIFICATION OF CONTRACT PURSUANT TO WHICH U.S. EXERCISED SECOND RENEWAL OPTION UNDER THAT VA NATIONAL CONTRACT

* ARALEZ PHARMA SAYS CONTRACT MODIFICATION EXTENDS TERM OF AGREEMENT TO APRIL 28, 2019 - SEC FILING

* ARALEZ PHARMA - MODIFICATION INCLUDES SAME PRICING TERMS DURING APRIL 29, 2017 THROUGH APRIL 28 ANNUAL TERM EXCEPT FOR PRICE DECREASE TO 200MG SKUS Source text - bit.ly/2EnPFGc Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below